Allergan Textured Implant Recall
Why the Recall for Allergan Textured Implants? There has been recurrent media coverage over the past year about a rare subtype of lymphoma that has been diagnosed in a small but increasingly reported number of women who have textured implants. It is called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). From the FDA website: BIA-ALCL is not breast cancer – it is a type of non-Hodgkin’s lymphoma (cancer of the immune system). In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body. At this time, the overall incidence of developing BIA-ALCL is considered to be low; however, a BIA-ALCL diagnosis is serious and can lead to death, especially if not diagnosed early or promptly treated. In most patients, BIA-ALCL is treated successfully with surgery to remove the implant and scar tissue surrounding the implant; however, Continue Reading →